Is brigatinib available in China?

Brigatinib (Brigatinib) is an innovative lung cancer treatment drug, a tyrosine kinase inhibitor, specifically designed for patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC). The emergence of this drug has brought new breakthroughs and hope to the field of lung cancer treatment.

Brigatinib is available as an oral tablet. Usually taken once daily, with or without food. Take brigatinib at about the same time each day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any parts you don't understand. Take brigatinib exactly as directed. Do not take more, less, or more often than prescribed by your doctor.

Brigatinib, with its unique mechanism, can precisely inhibit the activity of ALK kinase in lung cancer cells, thereby blocking the growth and spread of tumor cells. By interfering with the signal transduction pathways of tumor cells, it prevents cancer cells from obtaining the nutrients and support they need to survive, ultimately achieving the purpose of controlling disease progression.

In clinical practice, brigatinib has demonstrated significant efficacy and safety. Multiple studies have shown that brigatinib can effectively prolong survival and improve quality of life for patients with ALK-positive locally advanced or metastatic non-small cell lung cancer. At the same time, it can also cross the blood-brain barrier and exert a good therapeutic effect on patients with central nervous system involvement.

In addition, brigatinib is also relatively well tolerated, and patients can better adapt to the drug during use and reduce the occurrence of adverse reactions. This makes brigatinib one of the preferred treatment options for many lung cancer patients.

It is worth mentioning that the development of brigatinib is the result of countless efforts and wisdom of scientists. Its successful launch not only reflects the progress of medical technology, but also demonstrates mankind's firm belief and unremitting pursuit of defeating diseases.

Brigatinib is now on the market in China and has been included in the reimbursement items of medical insurance. For the domestic market90mg*For 28 pills of brigatinib, the price after reimbursement by medical insurance is about 6,000 yuan. It is worth mentioning that there are also several generic brigatinib drugs on the market in overseas markets such as Laos and Bangladesh. The prices of these drugs range from 900 yuan to 3,200 yuan, taking 90mg*30 tablets as an example. If a patient is interested in or needs an overseas version, he or she must seek consultation and obtain relevant information through a regular overseas medical consulting company.

In general, brigatinib occupies an important position in the field of lung cancer treatment with its innovative mechanism, significant efficacy and good safety. It provides new treatment opportunities for patients with ALK-positive non-small cell lung cancer and brings hope of life. With the deepening of research and the expansion of clinical application, we believe that brigatinib will bring good news to more patients.